Birdwatch Note
2024-12-25 21:50:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Este tuit desinforma al incluir dos capturas de pantalla de dos noticias que no tienen nada que ver. En España se está inmunizando con anticuerpos monoclonales frente al VRS. No se están utilizando vacunas, ya que aún están en ensayos clínicos. https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6465
Written by E0020CD050B79DF9DE850CF01EE5E6D229C7449E7FB46DBFAE2DBF9247337613
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1872029901517385912
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1872037245202600186
- noteId - 1872037245202600186
- participantId -
- noteAuthorParticipantId - E0020CD050B79DF9DE850CF01EE5E6D229C7449E7FB46DBFAE2DBF9247337613 Participant Details
- createdAtMillis - 1735163434683
- tweetId - 1872029901517385912
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Este tuit desinforma al incluir dos capturas de pantalla de dos noticias que no tienen nada que ver. En España se está inmunizando con anticuerpos monoclonales frente al VRS. No se están utilizando vacunas, ya que aún están en ensayos clínicos. https://www.sanidad.gob.es/gabinete/notasPrensa.do?id=6465
Note Ratings
| rated at | rated by | |
| 2024-12-26 05:09:08 -0600 | Rating Details | |
| 2024-12-25 17:08:59 -0600 | Rating Details | |
| 2024-12-25 16:23:04 -0600 | Rating Details | |
| 2024-12-26 12:47:09 -0600 | Rating Details | |
| 2024-12-26 10:28:27 -0600 | Rating Details | |
| 2024-12-26 07:42:49 -0600 | Rating Details | |
| 2024-12-26 09:28:57 -0600 | Rating Details | |
| 2024-12-26 09:10:10 -0600 | Rating Details | |
| 2024-12-26 07:42:29 -0600 | Rating Details | |
| 2024-12-26 04:45:55 -0600 | Rating Details | |
| 2024-12-26 03:54:56 -0600 | Rating Details | |
| 2024-12-26 03:00:48 -0600 | Rating Details | |
| 2024-12-26 02:07:56 -0600 | Rating Details | |
| 2024-12-25 16:43:57 -0600 | Rating Details | |
| 2024-12-27 06:42:16 -0600 | Rating Details | |
| 2024-12-26 14:36:08 -0600 | Rating Details | |
| 2024-12-26 07:22:09 -0600 | Rating Details | |
| 2024-12-26 03:55:25 -0600 | Rating Details |